Physician

Verna Luz Guanzon, M.D.

According to 2025 Medicare claims, Verna Guanzon, M.D. (NPI: 1861652331) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Amherst, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24572-3001. Guanzon is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Guanzon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 660 traditional Medicare patients, billed 17,981 HCPCS/CPT codes, and received $413,355 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 18,118 prescription claims across 934 beneficiaries totaling $1,417,185 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,008 claims. Open Payments data shows 188 records totaling $3,718. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $789,477 to $1,417,185. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	811	13,760	$292,716
2016	798	13,511	$300,554
2017	786	19,398	$326,952
2018	764	22,436	$400,871
2019	760	25,255	$400,944
2020	744	19,092	$376,962
2021	787	27,487	$406,195
2022	673	18,640	$387,085
2023	662	15,947	$396,989
2024	660	17,981	$413,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	868	15,317	$789,477
2016	870	15,941	$887,727
2017	778	16,063	$984,842
2018	802	15,211	$966,137
2019	804	14,852	$1,101,795
2020	829	15,767	$1,147,586
2021	869	16,092	$1,253,307
2022	889	16,413	$1,346,757
2023	929	17,234	$1,620,618
2024	934	18,118	$1,417,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	450	1,641	$54,546
2016	457	1,479	$34,891
2017	434	1,555	$33,687
2018	432	1,447	$31,187
2019	410	1,380	$31,340
2020	462	1,468	$46,071
2021	341	1,283	$49,424
2022	293	1,117	$51,149
2023	276	1,050	$54,881
2024	292	1,008	$56,569

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	559	1,053	$75
80061	Blood test, lipids (cholesterol and triglycerides)	540	916	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	470	747	$11
36415	Insertion of needle into vein for collection of blood sample	595	1,197	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	470	805	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	145	6,276	$205,717
Farxiga	Dapagliflozin Propanediol	129	7,094	$127,675
Eliquis	Apixaban	107	5,830	$113,094
Jardiance	Empagliflozin	87	5,130	$100,465
Januvia	Sitagliptin Phosphate	43	3,683	$67,503

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	66	$25,030
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	54	$3,874
A7032	Cushion for use on nasal mask interface, replacement only, each	N	15	33	$2,977
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	29	63	$2,936
E0601	Continuous positive airway pressure (cpap) device	Y	18	86	$2,540

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	188	$3,718	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Verna Luz Guanzon, M.D.?

Tedicare shows public-source Medicare data for Verna Luz Guanzon, M.D. (NPI 1861652331), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Verna Luz Guanzon, M.D. have ACO affiliation data?

Verna Luz Guanzon, M.D. is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Verna Luz Guanzon, M.D.?

Verna Luz Guanzon, M.D. is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Verna Luz Guanzon, M.D. have Open Payments data?

Verna Luz Guanzon, M.D. has 188 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.